Noul Co.,Ltd.

Equities

A376930

KR7376930004

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
2,885 ^KRW	+8.66%		+20.96%	-28.94%

Apr. 25	Noul Announces 2 Clinical Performance Studies At Pan-African Malaria Conference	CI
2023	Noul Co., Ltd. Unveils the Result of Malaria Study in Ethiopia and Ghana	CI

Noul co., ltd. has completed an IPO in the amount of KRW 15 billion.

February 24, 2022 at 12:00 am EST

noul co., ltd. has completed an IPO in the amount of KRW 15 billion.

Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 960,000
PriceRange: KRW 10000
Discount Per Security: KRW 400

Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 540,000
PriceRange: KRW 10000
Discount Per Security: KRW 400

Transaction Features: ESOP Related Offering

Latest news about Noul Co.,Ltd.

Noul Announces 2 Clinical Performance Studies At Pan-African Malaria Conference	Apr. 25	CI
Noul Co., Ltd. Unveils the Result of Malaria Study in Ethiopia and Ghana	23-10-23	CI
Noul Co., Ltd. Enters Cancer Diagnostic Business with the Launch of Cervical Cell Analysis Product	23-10-09	CI
Noul to Raise 30 Billion Won via Share Issuance; Shares Plunge 30%	23-07-04	MT
Noul Co. Ltd and The RIGHT Foundation Commences Research and Development for Supporting Malaria Control	23-03-27	CI
Noul co., ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-21	CI
Noul co., ltd. has completed an IPO in the amount of KRW 15 billion.	22-02-24	CI
Noul co., ltd. has filed an IPO.	21-08-26	CI

Chart Noul Co.,Ltd.

Duration

Period

More charts

Company Profile

Noul Co Ltd is a Korea-based company principally engaged in the next generation diagnostic testing platform business. The Company is engaged in the manufacture and sale of blood test diagnostic devices based on the artificial intelligence (AI) algorithms and diagnostic kits. In addition, the Company is also engaged in the provision of services such as regular monthly subscriptions and others through an integrated web-based remote diagnosis system.

Sector

Biotechnology & Medical Research

Calendar

09:00pm - Non-Deal Roadshow - Day 5

More about the company

Income Statement Evolution

More financial data

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
NOUL CO.,LTD.	-28.94%	78.77M
EXACT SCIENCES CORPORATION	-31.90%	9.3B
GUARDANT HEALTH, INC.	-6.25%	3.1B
BGI GENOMICS CO., LTD.	-13.96%	2.17B
VERACYTE, INC.	-16.83%	1.75B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+72.82%	1.5B
CAREDX, INC	+29.17%	807M
SEEGENE, INC.	-2.62%	759M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-26.33%	532M
CURIOX BIOSYSTEMS CO., LTD	+4.97%	313M

Bio Diagnostics & Testing